EXAS
Exact Sciences Corp
获取预测
在您的设备上获取AI股票预测
关于该公司
Exact Sciences Corp. develops and commercializes non-invasive molecular screening tests for the early detection and prevention of colorectal cancer. The DNA-based test helps identify precancerous conditions and the presence of cancer by detecting genetic mutations in colon cells.
立即获取AI股票预测
下载我们的AI股票预测实时应用
